• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Trokendi vs Qudexy

Quote

Anonymous

Guest
What are the differences between these two drugs?

From a quick look, differences seem to be that Qudexy capsules can be opened and sprinkled onto food and that Trokendi has a 6+month head start.
 
























I assume you are referring to the press release yesterday? What's the big deal? And you make it sound like our leadership is out to get us or something with your "spin this" comment. Whatever direction we get I am sure it will be in our best interest.
 








AG is no different than a brand. Only difference is if a Dr. Write Qudexy and substitution permitted, they can fill with Qudexy version II. Generics are cheap because there is no research (or very little) no copay programs, and most importantly, no sales force promoting it. Since USL has these things, the cost will be no different, thus making it a brand drug. This is desperation and the only way USL thinks they can gain market share.
 








































How many if the superus reps are banned from offices? U toss our cards n think that will make a difference in drs rx habits.

I have no clinical data on YOUR product
U tell people u have a migrane indication
What % of your scripts are on label?
 








Top Bottom
Back
Quote